| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| LogicBio Therapeutics, Inc. | Director | Common Stock | 0 | $2.01 | 16 Nov 2022 | Direct | |
| LogicBio Therapeutics, Inc. | Director | Stock Option (right to buy) | 0 | 16 Nov 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000089924322036299-moscicki-richard-a-2022-11-16 | LogicBio Therapeutics, Inc. | 16 Nov 2022 | 2 | $0 | 4 | Director | 17 Nov 2022, 20:09 |
| /report/000120919122038231-moscicki-richard-a-2022-06-17 | LogicBio Therapeutics, Inc. | 17 Jun 2022 | 1 | $0 | 4 | Director | 21 Jun 2022, 07:57 |
| /report/000120919121040425-moscicki-richard-a-2021-06-11 | LogicBio Therapeutics, Inc. | 11 Jun 2021 | 1 | $0 | 4 | Director | 14 Jun 2021, 20:00 |